case report aspiration during anesthesia glp-1 receptor agonist 2023 Are Serious Risks of Semaglutide and Other Agonists Under-Recognized? Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia Glucagon-Like Peptide-1 Receptor Agonists and
Description
Simultaneously, this study highlights the critical considerations for clinicians in administering these medications, including long-term safety, efficacy, potential adverse effects, and overall clinical utility
The STEP-HFpEF trial reflected similar outcomes
The considerable interindividual variation in baseline gastric half-emptying times is evident (Fig
Sometimes the highest number means a drug isnt covered
[DOI] [PubMed] [Google Scholar] 193.Marquez-Meneses J.D., Olaya-Bonilla S.A., Barrera-Carreo S., Tibaduiza-Arvalo L.C., Forero-Crdenas S., Carrillo-Vaca L., Rojas-Rodrguez L.C., Calderon-Ospina C.A., Rodrguez-Quintana J
In the case of I-M-150847, despite reduced cAMP generation, GSIS is comparable to liraglutide
